• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
Trending:
  • Kashmir
  • Elections
Thursday, June 25, 2026

Daily Times

Your right to know

  • HOME
  • Latest
  • Iran-Israel war
  • Gilgit Baltistan Election
  • Pakistan
    • Balochistan
    • Gilgit Baltistan
    • Khyber Pakhtunkhwa
    • Punjab
    • Sindh
  • World
  • Editorials & Opinions
    • Editorials
    • Op-Eds
    • Commentary / Insight
    • Perspectives
    • Cartoons
    • Letters to the Editor
    • Featured
    • Blogs
      • Pakistan
      • World
      • Lifestyle
      • Culture
      • Sports
  • Business
  • Sports
  • E-PAPER
    • Lahore
    • Islamabad
    • Karachi

Web Desk

Pakistan allows third Chinese vaccine for emergency use

Published on: April 9, 2021 11:06 AM

chinese vaccine

In the middle of the third wave of coronavirus and record high cases, Drug Regulatory Authority of Pakistan (DRAP) has granted Emergency Use Authorization (EUA) of another Chinese vaccine, CoronaVac.

CoronaVac would be the third Chinese and fifth overall vaccine that is being used in Pakistan currently.

Pakistan had earlier granted emergency use of the two-dose SinoPharm and the single dose Convidencia developed by CanSino Biologicals Inc, in China. DARP has also approved the usage of UK’s AstraZeneca and the Russian Sputnik V.

According to sources, CoronaVac was approved by health authorities to tackle the third wave of coronavirus, despite the vaccine having low efficacy.

“DRAP’s registration board in its 304th meeting on Thursday gave Emergency Use Authorisation (EUA) to CoronaVac vaccine, developed by the Sinovac Life Sciences Company Ltd., based in Beijing, China.”, DARP official said.

Pakistan currently has two Chinese and one Russian vaccine in use for public and private sectors. The country expects the AstraZeneca vaccine under the COVAX program but has not received its share due to supply constraints.

The national tally of total active Covid-19 cases was recorded at 66,994 as 5,329 more people tested positive for the deadly virus on Thursday, the highest number of single day cases since June last year.

Ninety-eight patients died on Thursday, 90 of whom were under treatment in hospitals and eight in their respective quarantines or homes, according to the latest update issued by the National Command and Operation Centre (NCOC). Most of the deaths occurred in Punjab, followed by Khyber Pakhtunkhwa.

Out of the total 98 deaths, 31 of the deceased died on ventilators during their treatment. The maximum ventilators were occupied in four major areas including Multan 81 percent, Islamabad Capital Territory (ICT) 58 percent, Gujranwala 84 percent and Lahore 75 percent. The maximum oxygen beds were occupied in four major areas of Swat 63 percent, Gujranwala 85 percent, Peshawar 83 percent and Gujrat 73 percent. Around 467 ventilators were occupied elsewhere in the country while no Covid-affected person was on ventilator in Gilgit Baltistan (GB) and Balochistan.

Filed Under: Pakistan, Top Stories Tagged With: coronavac, lead, Pakistan, sinovac

Submit a Comment




Primary Sidebar




Latest News

France announces first Ebola case

PM hails economic team for delivering ‘relief-oriented’ budget

Russia says nuclear weapons the ‘only’ guarantee against global war

French mountaineer dies as avalanche hits GB’s K-6 peak

Sanaullah rejects claim of no serious effort to resolve AJK situation

Pakistan

PM hails economic team for delivering ‘relief-oriented’ budget

French mountaineer dies as avalanche hits GB’s K-6 peak

Sanaullah rejects claim of no serious effort to resolve AJK situation

Aurangzeb expresses gratitude over passage of federal budget

Azma meets mourning congregation organisers to ensure peaceful Ashura observance

More Posts from this Category

Business

Pakistan and Iran pledge deeper cooperation for regional stability

PSX surges 1,600 points on buying

Punjab launches crackdown on tax defaulters

Pakistan’s Auditor General flags major budget irregularities

SIFC clears 435-km fuel pipeline linking Punjab to northwest

More Posts from this Category

World

France announces first Ebola case

Russia says nuclear weapons the ‘only’ guarantee against global war

IAEA expects Iran inspections to resume

More Posts from this Category




Footer

Home
Lead Stories
Latest News
Editor’s Picks

Culture
Life & Style
Featured
Videos

Editorials
OP-EDS
Commentary
Advertise

Cartoons
Letters
Blogs
Privacy Policy

Contact
Company’s Financials
Investor Information
Terms & Conditions

Facebook
Twitter
Instagram
Youtube

© 2026 Daily Times. All rights reserved.

Manage Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}